acement Therapy: Infusion of clotting factor concentrates to prevent or control bleeding episodes. Prophylactic Treatment: Regular infusions to maintain adequate clotting factor levels, reducing bleeding risks. Gene Therapy: Emerging treatments aimed at correctin
n hemophilia due to deficiency of intrinsic pathway factors. Genetic Testing: Identifies mutations in clotting factor genes. Family History Evaluation Understanding family medical history can be crucial, especially considering the hereditary nature of the disorder. Treatment Optio
clot formation. Types and Severity Hemophilia A is classified based on the residual activity level of factor VIII: Severe: <1% activity; spontaneous bleeding episodes are common. Moderate: 1-5% activity; bleeding typically occurs after minor injuries. Mild: 6-40% activity; bleeding
